Work

Abstract 6066: Preclinical evaluation of toxicity reduction for ROSE12, a novel ATP-dependent anti-CTLA-4 Switch antibody™ with FcγR affinity-enhanced Fc

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-6066

Authors: Moe Yoshimoto, Hiroki Hayashi, Kanako Tatsumi, Hitoshi Katada, Toshiaki Tsunenari, Hiroaki Susumu, Kenji Nakagawa, Hiroaki Nagano, Saki Michisaka, Chie Kato, Junko Shinozuka, Hiroshi Tanaka, Takehisa Kitazawa, Mika Kamata-Sakurai, Tomoyuki Igawa

Institution: Chugai Pharmaceutical Co., Ltd. (Japan)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409629395

Cites:

Cited by:

Related to: 10